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Abstract
The bacterial type VI secretion system (T6SS) is a large multi-component, dynamic
macromolecular machine that plays an important role in the ecology of many Gram negative
bacteria. T6SS is responsible for translocation of a wide range of toxic effector molecules
allowing predatory cells to kill both prokaryotic as well as eukaryotic prey cells1-5. The T6SS
organelle is functionally analogous to contractile tails of bacteriophages and is thought to attack
cells by initially penetrating them with a trimeric protein complex called the VgrG spike6,7.
Neither the exact protein composition of the T6SS organelle nor the mechanisms of effector
selection and delivery are known. Here we report that proteins from the PAAR (Proline-Alanine-
Alanine-aRginine) repeat superfamily form a sharp conical extension on the VgrG spike, which is
further involved in attaching effector domains to the spike. The crystal structures of two PAAR-
repeat proteins bound to VgrG-like partners show that these proteins function to sharpen the tip of
the VgrG spike. We demonstrate that PAAR proteins are essential for T6SS- mediated secretion
and target cell killing by Vibrio cholerae and Acinetobacter baylyi. Our results suggest a new
model of the T6SS organelle in which the VgrG-PAAR spike complex is decorated with multiple
effectors that are delivered simultaneously into target cells in a single contraction-driven
translocation event.
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tThe T6SS organelle is a 1000 nm-long tubular structure consisting of an inner tube made of
multiple copies of the Hcp protein and an external contractile sheath composed of VipA and
VipB proteins (also called TssB/TssC in the literature)3. It has been visualized in two
conformations (extended and contracted), which are both attached to the cell envelope by
means of a baseplate complex3. Rapid contraction of the sheath results in translocation of
the inner tube out of the predator cell and into the prey cell3. The trimeric VgrG spike
protein is positioned at the end of the tube7. It is believed to penetrate the prey cell with its
needle-shaped C-terminal β -helical domain. VgrG proteins can contain additional C-terminal
domains that act as effectors6 and may also bind effectors through undefined mechanisms8.
Because VgrG proteins are orthologous to the central baseplate spikes of bacteriophages
with contractile tails, we reasoned that additional structural components present in certain
phage spikes might have corresponding orthologous components in T6SS. The cryoEM
reconstruction of phage T4 baseplate shows that an unknown protein with a molecular
weight between 7 and 23 kDa binds to the tip of the β -helical domain of the central spike
protein gp5 9. We analyzed all known genes encoding small proteins in phage genomes with
gp5-like spikes and compared them to T6SS genes. Proteins containing the PAAR-repeat
motif were strongly represented in this group with gp5.4 being the corresponding protein of
T4 phage. Furthermore, genes encoding proteins with PAAR motifs were frequently found
immediately downstream from vgrG-like genes suggesting that the two are genetically
linked7. Therefore, we devised a strategy to test the hypothesis that these PAAR proteins
were binding to the tip of gp5 and VgrG proteins.
Careful examination of VgrG sequences showed that a β -structural repeat, which is
presumed to be responsible for β -helix formation6,10, either extends to the very C terminus
of the protein or terminates with a glycine/serine-rich stretch (Extended Data Fig. 1). We
surmised that the glycine/serine-rich stretch bends the polypeptide chain away from the β -
helix without disturbing its tip, and that all VgrG β -helices have blunt ends resembling that
of T4 gp5 β -helix. The X-ray crystal structure of one full-length VgrG trimer supports this
conclusion (Sycheva LV, Shneider MM, Basler M, Ho B, Mekalanos JJ, Leiman PG. In
preparation). Thus, we further hypothesized that the binding site for a PAAR protein was the
blunt end of the β -helix and designed experiments to test this supposition.
Due to solubility problems of most tested VgrG and PAAR proteins, we used a soluble
fragment of T4 gp5 β -helix (residues 484-575), which is known to fold into a stable native-
like trimeric structure, as a platform for creating β -helices mimicking the blunt end of
various VgrG spikes. We replaced the tip of gp5 β -helix (the last two β -strands) with an
equivalent fragment from several putative β -helices of VgrGs from Escherichia coli, Vibrio
cholerae and Pseudomonas aeruginosa (Extended Data Fig. 1). These gp5-VgrG chimeras
were then co- expressed with various PAAR proteins in cis and in trans in different
combinations (Extended Data Fig. 1). Surprisingly, the VCA0105 and c1882 PAAR proteins
were found to bind not only to the ends of their endogenous VgrG proteins but also to the
non-mutated wild type end of the gp5 β -helix as well.
The gp5-c1882 and gp5-VCA0105 complexes were purified to homogeneity and crystallized
(Extended Data Table 1). The structures were solved by molecular replacement11 using the
corresponding gp5 β -helix fragment as a search model10. In both complexes, a single chain
of the PAAR protein folds into a symmetrical cone-shaped structure with a sharp tip and a
triangular base fully occupying the blunt end of the β -helix (Fig. 1). The cone contains 9
short β -strands, three of which create its base and participate in binding to gp5 and six others
form three β -hairpins that point toward the vertex of the cone, but have different lengths.
The PAAR proteins interact with the gp5 β -helix via a virtually flat hydrophobic patch and
14 or 16 hydrogen bonds for c1882 or VCA0105, respectively (Extended Data Fig. 2). In
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tboth proteins, 12 hydrogen bonds between the main chain atoms of the tip of gp5 and those
of the PAAR domain form a perfect triangle surrounding the central hydrophobic patch
creating a unique binding platform (Extended Data Fig. 3). PISA software12 shows that
~16.5% of the PAAR protein surface is buried in this interface and the free energy of
interaction between the VgrG tip and c1882 or VCA0105 PAAR proteins is −5.5 kcal/mol or
−3.4 kcal/mol, respectively.
The fold of the PAAR protein is stabilized by a Zn atom positioned close to the cone’s
vertex (Fig. 1d, Extended Data Fig. 4). The Zn binding site consists of three histidines and
one cysteine - H14, H46, H54 and C81 in VCA0105 - that are very well conserved in close
homologs (Extended Data Fig. 5a). These residues are replaced with similar or
complementary metal-binding residues (arginines, lysines and glutamines) in more distant
homologs suggesting that they also carry a metal ion roughly at the same position. The metal
ion, being a natural ligand for this site, stabilizes the pointed tip of the PAAR domain and is
likely to be important for its integrity during penetration of the target cell envelope.
The PAAR motif sequence is also conserved, albeit to a lower degree than the Zn binding
site (Extended Data Fig. 5a). The PAAR motif functions to stabilize the fold by forming the
central part of the structure where the three parts of the polypeptide chain meet and
intertwine (Extended Data Fig. 5b, 5c). The three PAAR motifs interact with each other
through the main chain hydrogen bonds that are shielded by hydrophobic residues from all
sides (Fig. 1d). The distance between the C-alpha atoms of the third residue of the three
PAAR motifs in both proteins is only 5.3±0.1 Å (Extended Data Fig. 5b, 5c). c1882 and
VCA0105 show 61.3% sequence identity and as a consequence the two structures are very
similar with a root mean square deviation (RMSD) of 0.53 Å between all the 94 Cα  atoms
comprising the backbone (Extended Data Fig. 6).
Given such a critical location of PAAR proteins within the T6SS organelle and their high
structural conservation, we hypothesized that inactivation of PAAR genes would likely
interfere with T6SS functions including protein secretion and prey cell killing. Because
some T6SS+ organisms have many gene products predicted to carry the PAAR motif, we
focused on Vibrio cholerae strain 2740-80 and Acinetobacter baylyi ADP1, which each
encode only two and three PAAR proteins, respectively. In A. baylyi inactivation of all three
PAAR genes (aciad0051, aciad0052, aciad2681) led ~90% reduction in Hcp secretion
(Extended Data Fig. 7) and at least a 10,000-fold decrease in T6SS-dependent killing of E.
coli (Fig. 2a, 2c). Similarly, inactivation of both genes (vca0105 and vca0284) that encode
PAAR proteins in V. cholerae 2740-80 resulted in a ~100-fold decrease in T6SS-dependent
killing of E. coli and ~70% reduction in Hcp secretion (Fig. 2b, 2c; Extended Data Fig. 7).
Remarkably, in both bacterial species, mutants inactivated in single PAAR genes showed no
or only a modest defect in the functionality of their T6SS apparatus (Fig 2) indicating that
PAAR proteins within a species are interchangeable. We further attempted to complement
these double and triple PAAR mutants with heterologous PAAR genes but these
experiments were inconclusive (Extended Data Fig. 8). Thus, PAAR proteins may be very
specific for their cognate VgrG proteins in the context of the functional T6SS organelle.
The dramatic reduction in Hcp secretion in the triple PAAR gene knockout mutant of A.
baylyi suggests that PAAR proteins participate in the assembly of the T6SS complex by
either nucleating the folding of VgrG trimers or regulating their incorporation into the T6SS
organelle. Similar to the T4 phage system in which mutants lacking gp5 (VgrG ortholog) are
tailless13, any disruption in VgrG trimeric assembly will likely block the assembly of the
T6SS organelle. Alternatively, PAAR proteins may be important for another function of the
apparatus such as translocation of the VgrG spike through the predator outer membrane
during a sheath contraction event.
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tThe PAAR-repeat proteins form a diverse superfamily called CL15808 in the CDD
database14 that contains three families PF05488, COG4104, and PF13665 (or DUF4150).
The first two families are similar and describe PAAR domains that are on average ~95
residues long whereas the PF13665 family is somewhat more distant and its typical
members contain ~130 amino acids. The crystal structures reported here include
representatives of the PF05488 family. Hundreds of hypothetical proteins in the database
contain PAAR domains that are extended both N- and C-terminally by domains with various
predicted functions (Extended Data Fig. 9). The crystal structure shows that the termini of
the PAAR domain are open to solution and thus can be extended without distorting the
VgrG binding site (Fig. 1, Extended Data Fig. 6).
The C-terminal domains of many hypothetical PAAR proteins are predicted to have various
enzymatic activities that are toxic for prokaryotic and eukaryotic cells (Extended Data Fig.
9). Very similar putative effector domains can be found fused to the C-termini of VgrG
proteins (e.g., VIP2 ADP-ribosyl transferase). Binding of these larger PAAR proteins to the
tip of VgrG spikes would decorate the T6SS spike with a great variety of effector domains.
To test this hypothesis, we expressed a vsvG epitope-tagged version of the ACIAD2681
PAAR protein in the WT A. baylyi ADP1 and in its triple PAAR gene knockout mutant
(Fig. 3). The epitope-tagged protein was secreted by T6SS and fully restored T6SS-
mediated killing of E. coli in the triple PAAR gene knockout strain (Fig. 2a, 3), suggesting
that other effector proteins fused to PAAR domains will likely also be targeted for secretion
by binding the tip of VgrG trimers.
VCA0284, the larger of the two V. cholerae V52 PAAR proteins, carries a transthyretin
domain (TTR) at its C terminus, which is a very common architecture of PAAR proteins
(Extended Data Fig. 9). TTR is an immunoglobulin-like domain that is known to form
oligomeric structures in which these domains interact with each other or with other
partners15. Thus, PAAR-associated TTR domains may act as adapters to further decorate the
VgrG tip with effectors displaying TTR domains or serve to bind the spike to other TTR
domain-containing proteins such as the TssJ/SciN lipoprotein16, an outer membrane
structural component of the T6SS “baseplate”3.
Besides being in T6SS gene clusters, many PAAR genes are frequently found downstream
of vgrG genes6, which in turn, are often encoded by Rhs elements (accessory sequences that
have the hallmarks of horizontally acquired DNA, Extended Data Fig. 9). A recent report17
shows that two different nucleases encoded by the rhsA and rhsB genes of Dickeya dadantii
are delivered into target cells in a VgrG-dependent process, suggesting that the T6SS locus
of this organism mediates translocation of these effectors. Interestingly, both RhsA and
RhsB proteins contain PAAR repeat regions and other features that categorize them as Class
7 PAAR domain architecture proteins (Extended Data Fig. 9b). Thus, our working model
(Fig. 4) predicts that these T6SS nuclease effectors should bind to the tip of VgrG trimers
through their PAAR repeat domains and in this way be targeted for secretion and
translocation into prey cells.
The structural, functional, and bioinformatic findings summarized above allow us to make
several conclusions and predictions. Because a PAAR-repeat protein caps the end of the β -
helix of a VgrG spike, it is in fact the piercing tip that is responsible for the initial event of
creating an opening in the target cell envelope. Furthermore, because the crystal structure
demonstrates that the canonical PAAR-repeat domain can be extended N- or C-terminally
without distorting its structure or its VgrG β -helix binding site, we predict that large PAAR
proteins carrying effector domains will likely also bind to VgrG spikes and be translocated
into target cells by the T6SS organelle. Considering the findings reported here and other
published data we propose that there are five mechanisms by which effectors can be
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tincorporated into the T6SS spike complex (Fig. 4). Three of them – 1) C-terminal extensions
of the VgrG spike6, 2) Binding surface features on the VgrG protein8,18, and 3) N- or C-
terminal extensions of the PAAR protein17 – have direct or indirect experimental evidence.
Two others – 4) Binding surface features or additional domains (e.g., the TTR domain) on
PAAR proteins and 5) Incorporation into the cavity formed by the gp27 domain of VgrG –
remain speculative. Thus, the T6SS machine may be capable of delivering a multifunctional
‘cargo’ – or Multiple Effector TRanslocation VgrG (MERV) spike – into the target prey
cell in a single molecular translocation event driven by T6SS sheath contraction.
Methods
Cloning and protein expression
The gp5 fragment containing residues 484-575 was cloned into the in-house designed
expression vector pEEva2 with the help of the In-Fusion system (Clontech). The pEEva2
vector is a derivative of the pET-23a expression plasmid (Novagen) with a modified
multiple cloning region. The T7-tag was replaced with a MGSSH6SSG polyhistidine tag
(His-tag) followed by a sequence containing a tobacco etch virus (TEV) protease cleavage
site (ENLYFQ^GSGS). Upon expression and after TEV cleavage, the gp5 fragment
contained four residues (GSGS) upstream of residue 484. The C-terminal residues of gp5
were modified by performing PCR with long primers containing the required mutations
(Extended Data Fig. 1).
For expression in cis, PAAR genes were cloned downstream from the gp5 fragment. The
spacer between the stop codon of gene 5 and the first codon of PAAR genes contained a
standard ribosome binding sequence and was about 15 bases long.
For expression in trans, PAAR genes were cloned into the pATE vector (chloramphenicol
selection), which is a modified version of the pACYCDuet-1 expression plasmid (Novagen).
The dual cloning site of the pACYCDuet-1 vector was replaced by the multiple cloning site
from the pEEva2 vector. The cloned PAAR proteins retained their wild type N and C
termini (i.e. were tag-free).
Expression and purification of gp5-PAAR complexes
Gp5-PAAR complexes were expressed in Escherichia coli B834(DE3) cells grown in the
2×TY medium containing ampicillin at 100 μ g/ml for the cis constructs and, additionally,
chloramphenicol at 34 μ g/ml for the trans constructs. The cultures with a total volume of 2
liters were incubated at 37° C with shaking at 200 rpm until the culture reached the optical
density (OD) of 0.6 (600 nm wavelength). The culture was cooled down to 18°C, and the
protein expression was induced by an addition of isopropyl-β -D-thiogalactoside to a final
concentration of 1 mM. The expression continued overnight.
The cells were harvested on the following day by centrifugation at 8000 g at 4°C for 10 min.
The cell pellet was resuspended in a lysis buffer that contained 50 mM TrisCl pH 8.0, 300
mM NaCl, 5 mM Imidazole. The cells were lysed by ultrasonication, which was performed
on ice with the temperature of the lysate maintained below 10° C. The lysate was then
centrifuged at 25000 g, 4°C for 10 min. The supernatant was applied to a Ni column (5ml
GE HisTrap FF Crude). The non-specifically bound material was removed by washing the
columns with 10 column volumes of a washing buffer (50 mM TrisCl pH 8.0, 300 mM
NaCl, 20 mM Imidazole. The affinity bound material was eluted with 10 column volumes of
an elution buffer (20mM TrisCl pH 8.0, 300mM NaCl, 250mM Imidazole).
The fractions containing the target protein were pulled together and the TEV protease was
added to have a concentration of 10% (w/w) of the target protein. The mixture was then
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tplaced into a dialysis bag, and the proteolysis continued overnight with a simultaneous
dialysis against a buffer optimal for TEV cleavage (10mM TrisCl pH 8.0, 3mM DTT,
1.5mM EDTA). The digested protein was further purified by ion-exchange chromatography
performed with a GE Mono Q 10/100 GL column connected to an AKTApurifier 100
system (GE Healthcare Life Sciences). The sample was loaded onto the column that was
equilibrated with buffer A (20mM TrisCl pH 8.0) and eluted with a linear gradient against
buffer B (20mM TrisCl pH 8.0, 1M NaCl). The gradient extended from 0% to 65% of the
buffer B concentration. Relevant fraction were combined and concentrated using Sartorius
ultrafiltration devices with a molecular weight cutoff of 10,000 to a volume of ~5ml. This
sample was then loaded onto a GE HiLoad 16/60 Superdex 200 size-exclusion column pre-
equilibrated with 10mM TrisCl pH 8.0, 150mM NaCl. The fractions containing pure
gp5G484-PAAR complexes were combined and concentrated to 25 mg/ml with the help of a
similar Sartorius ultrafiltration devices and without changing the buffer. The protein was
stored in the same buffer at +4°C until it was used for crystallization. All purification buffers
and the final protein solution contained NaN3 at a concentration of 0.02% (w/v).
Identification of gp5-PAAR complexes
The purification procedure employed metal affinity chromatography based on the N-
terminal His-tags of gp5 fragments with slightly modified C-termini (Extended Data Fig. 1),
and thus led to accumulation of two protein species - gp5-PAAR complexes and gp5
fragments alone. The β -helical fragment of gp5 used in this study does not fully denature in
sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE), and runs as several species with
apparent molecular weights (MW) of 10-30 kDa. Most of the PAAR proteins (MW ~9.7
kDa) had the same SDS-PAGE mobility as the fastest migrating band of gp5 fragments
(MW ~10 kDa). However, these species were easily separable by a combination of high
resolution anion exchange and analytical size exclusion chromatographies (monoQ and
Superdex 75 resins, respectively). The gp5 fragment is a highly negatively charged β -helix10
that binds to the monoQ anion exchange resin strongly. Consequently, gp5 fragments that
were free from PAAR proteins eluted from the monoQ resin by a buffer with a specific
conductivity of 24-29 mS/cm. All gp5-PAAR complexes discussed in this paper were found
to be much weaker anionic binders and eluted from the monoQ resin by a buffer with a
specific conductivity of 18-25 mS/cm. Furthermore, size exclusion profiles (Superdex 75
10/300 GL) of all gp5- PAAR complexes had only one peak centered at 10.34±0.06 ml,
whereas gp5 fragments free from PAAR proteins formed various oligomers and eluted at
different positions of the chromatogram. The VCA0284 PAAR protein containing the
transthyretin domain was prone to aggregation and the gp5-VCA0284 complex was
unsuitable for size-exclusion chromatography. Expression of VCA0284 in the presence of
the gp5_VCA0018 or gp5_VCA0123 chimeras led to an almost complete loss of gp5 from
solution indicating complex formation.
Crystallization and structure determination of gp5-PAAR complexes
The initial crystallization screening was carried out by the sitting drop method in 96 well
SWISSCI 2-lens MRC plates using Jena Bioscience crystallization screens. Bio-Tek
Precision XS and TTP Labtech mosquito pipetting robots were employed for preparing
crystallization plates and setting up drops each containing 200 nl of the protein and the same
volume of the well solution. Optimization of crystallization conditions was performed in 24
well SuperClear plates and thick siliconized cover slides (both from Jena Bioscience) by
hanging drop vapor diffusion. Crystallization drops of the 24-well plate setup contained 1.25
μ l of the protein solution in 10 mM TrisCl pH 8.0, 150 mM NaCl mixed with an equal
volume of the well solution. Best crystals of the gp5-c1882 complex were obtained with the
protein having the initial concentration of 13.5 mg/ml and equilibrated against 500 μ l of the
well solution containing 100-150 mM CaCl2, 13-15% PEG 3350, 100 mM MES pH 6.5.
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tBest crystals of the gp5-VCA0105 complex were obtained with the protein at 15 mg/ml and
equilibrated against 500μ l of the well solution containing 13-14% PEG 2000, 100 mM
NaAc pH 5.0.
For data collection, the crystals were dipped for 20-45 seconds into cryo solutions
containing either 30% of glycerol for gp5-c1882 or 25% of 2-methyl-2,4-pentanediol for
gp5- VCA0105 in addition to the well solution components and flash frozen in a vaporized
nitrogen stream at 100 K. Collection of diffraction data and fluorescent scans was carried
out at the PXI and PXIII beam lines of the Swiss Light Source (SLS) at the Paul Scherrer
Institute (Villigen, Switzerland), respectively, using X-rays with a wavelength of 1.000 Å
for both crystals. Best gp5-c1882 and gp5-VCA0105 crystals diffracted to 3.4 Å and 1.9 Å
resolution limits, respectively. The diffraction data was indexed, integrated, and scaled with
XDS27 (Extended Data Table 1). The structure of the gp5-c1882 complex was solved by
molecular replacement with PHASER19 using a fragment of the gp5-gp27 complex crystal
structure containing residues 484-575 of gp5 (PDB ID 1K28) as a search model10. As the
asymmetric unit contained four gp5-c1882 complexes, non-crystallographic symmetry
(NCS) averaging was used to improve the electron density prior to model building. The
model was built manually with COOT28 and refined with REFMAC521 and PHENIX20
using NCS for torsion angles restraints. The structure of gp5-c1882 was subsequently used
as a search model to solve the structure of the gp5-VCA0105 complex by molecular
replacement with PHASER19. There was only one complex per asymmetric units. The
structure was refined with PHENIX20 and COOT28.
Both refined structures, gp5-VCA0105 and gp5-c1882, had excellent stereochemical
parameters (see also Extended Data Table 1). All main chain dihedral angles of the gp5-
VCA0105 structure were found in the most favored regions of the Ramachandran plot. The
gp5-c1882 structure had 97.3 % of its main chain dihedral angles in the most favored
regions of the Ramachandran plot, 2.7% in the additionally allowed regions, and none in the
disallowed region.
Bioinformatics
Putative orthologs of PAAR repeat proteins were identified with the help of HMMER23. A
search for high confidence hits to PFAM29 domains PF05488 or PF13665 that describe the
two distinct PAAR repeat domains resulted in 1353 PAAR domain-containing proteins.
Phage proteins and orphan genes were excluded from this analysis. Functional assignment of
extension domains was based on high confidence hits obtained with the help HHpred24,
HMMER23, CDD14, and CDART25 web services.
Bacterial killing assays
Overnight cultures of V. cholerae 2740-80, A. baylyi ADP1 and E. coli MG1655 were
washed in LB and diluted 50-200× into fresh LB and cultivated for 2.5–3.5 hr to reach the
OD of ~0.5–1.0. Cells were pelleted by centrifugation at 4,000×g for 5 minutes and mixed at
OD ~10 in 1:1 ratio. After 2 hr at 37 C, bacterial spots were cut out and the cells were
resuspended in 1 ml LB. The cellular suspension was serially diluted in LB, and 5 μ l of the
suspensions was spotted on selective plates (streptomycin for V. cholerae and A. baylyi, and
gentamicin for E. coli). aciad2681 was expressed basally from the plasmid pMMB67EH 26.
PAAR protein complementation in V. cholerae was done by cloning the indicated PAAR
genes into pBAD24 30 and inducing with the appropriate concentrations of L-arabinose.
Two- tailed Student’s t-test was used to interpret the statistical significance of the number of
the colony forming units.
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Overnight cultures of V. cholerae 2740-80 and A. baylyi ADP1 were washed in LB and
diluted 200× into fresh LB and cultivated for 5 hr at 37 C. 1 mL of culture supernatants were
passed through 0.2 μ M filter, precipitated with TCA, subjected to 12% SDS-PAGE and
stained with Coomassie Blue. The recombinantly expressed ACIAD2681 PAAR protein
carried a C-terminal vsvG epitope tag (YTDIEMNRLGK). Western blots were performed
on the TCA precipitated samples following standard methodology using anti-vsvG primary
antibodies (Sigma). Band intensities were quantified using the Fiji software31.
Molecular graphics
UCSF Chimera32 was used to prepare Figure 1 and Extended Data Figures 2-6.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank the entire staff of the Swiss Light Source PX beamlines and Dr. Vincent Olieric in particular for support
related to crystallographic data collection. The project was made possible by the Swiss National Science
Foundation (grant 31003A_127092) and EPFL funding to P.G.L., and grants AI-026289 and AI-01845 from the
NIAID to J.J.M.
References
1. Pukatzki S, et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae
using the Dictyostelium host model system. Proc Natl Acad Sci U S A. 2006; 103:1528–33.
[PubMed: 16432199]
2. Mougous JD, et al. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion
apparatus. Science. 2006; 312:1526–30. [PubMed: 16763151]
3. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ. Type VI secretion requires a
dynamic contractile phage tail-like structure. Nature. 2012; 483:182–6. [PubMed: 22367545]
4. Kapitein N, Mogk A. Deadly syringes: type VI secretion system activities in pathogenicity and
interbacterial competition. Curr Opin Microbiol. 2013
5. Basler M, Ho BT, Mekalanos JJ. Tit-for-Tat: Type VI Secretion System Counterattack during
Bacterial Cell-Cell Interactions. Cell. 2013; 152:884–94. [PubMed: 23415234]
6. Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. Type VI secretion system translocates a
phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A.
2007; 104:15508–13. [PubMed: 17873062]
7. Leiman PG, et al. Type VI secretion apparatus and phage tail-associated protein complexes share a
common evolutionary origin. Proc Natl Acad Sci U S A. 2009; 106:4154–9. [PubMed: 19251641]
8. Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ. Identification of T6SS-dependent effector and
immunity proteins by Tn-seq in Vibrio cholerae. Proc Natl Acad Sci U S A. 2013; 110:2623–8.
[PubMed: 23362380]
9. Kostyuchenko VA, et al. Three-dimensional structure of bacteriophage T4 baseplate. Nat Struct
Biol. 2003; 10:688–93. [PubMed: 12923574]
10. Kanamaru S, et al. Structure of the cell-puncturing device of bacteriophage T4. Nature. 2002;
415:553–557. [PubMed: 11823865]
11. Rossmann MG, Blow DM. The detection of sub-units within the crystallographic asymmetric unit.
Acta Crystallographica. 1962; 15:24–31.
12. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol.
2007; 372:774–97. [PubMed: 17681537]
Shneider et al. Page 8
Nature. Author manuscript; available in PMC 2014 February 15.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t13. Kikuchi Y, King J. Genetic control of bacteriophage T4 baseplate morphogenesis. II. Mutants
unable to form the central part of the baseplate. J Mol Biol. 1975; 99:673–694. [PubMed: 765482]
14. Marchler-Bauer A, et al. CDD: conserved domains and protein three-dimensional structure.
Nucleic Acids Res. 2013; 41:D348–52. [PubMed: 23197659]
15. Hamburger ZA, Brown MS, Isberg RR, Bjorkman PJ. Crystal structure of invasin: a bacterial
integrin-binding protein. Science. 1999; 286:291–5. [PubMed: 10514372]
16. Felisberto-Rodrigues C, et al. Towards a structural comprehension of bacterial type VI secretion
systems: characterization of the TssJ-TssM complex of an Escherichia coli pathovar. PLoS Pathog.
2011; 7:e1002386. [PubMed: 22102820]
17. Koskiniemi S, et al. Rhs proteins from diverse bacteria mediate intercellular competition. Proc Natl
Acad Sci U S A. 2013; 110:7032–7. [PubMed: 23572593]
18. Hachani A, et al. Type VI secretion system in Pseudomonas aeruginosa: secretion and
multimerization of VgrG proteins. J Biol Chem. 2011; 286:12317–27. [PubMed: 21325275]
19. McCoy AJ, et al. Phaser crystallographic software. Journal of applied crystallography. 2007;
40:658–674. [PubMed: 19461840]
20. Adams PD, et al. The Phenix software for automated determination of macromolecular structures.
Methods. 2011; 55:94–106. [PubMed: 21821126]
21. Murshudov GN, et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta
Crystallogr D Biol Crystallogr. 2011; 67:355–67. [PubMed: 21460454]
22. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr
D Biol Crystallogr. 2010; 66:486–501. [PubMed: 20383002]
23. Finn RD, Clements J, Eddy SR. HMMER web server: interactive sequence similarity searching.
Nucleic Acids Res. 2011; 39:W29–37. [PubMed: 21593126]
24. Soding J, Biegert A, Lupas AN. The HHpred interactive server for protein homology detection and
structure prediction. Nucleic acids research. 2005; 33:W244–8. [PubMed: 15980461]
25. Geer LY, Domrachev M, Lipman DJ, Bryant SH. CDART: protein homology by domain
architecture. Genome research. 2002; 12:1619–23. [PubMed: 12368255]
26. Furste JP, et al. Molecular-Cloning of the Plasmid Rp4 Primase Region in a Multi-Host-Range
Tacp Expression Vector. Gene. 1986; 48:119–131. [PubMed: 3549457]
27. Kabsch W. XDS. Acta crystallographica. Section D, Biological crystallography. 2010; 66:125–32.
28. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol
Crystallogr. 2004; 60:2126–32. [PubMed: 15572765]
29. Finn RD, et al. The Pfam protein families database. Nucleic acids research. 2010; 38:D211–22.
[PubMed: 19920124]
30. Guzman LM, Belin D, Carson MJ, Beckwith J. Tight regulation, modulation, and high-level
expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995; 177:4121–30.
[PubMed: 7608087]
31. Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;
9:676–82. [PubMed: 22743772]
32. Pettersen EF, et al. UCSF Chimera--a visualization system for exploratory research and analysis.
Journal of computational chemistry. 2004; 25:1605–12. [PubMed: 15264254]
33. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol
Biol. 1982; 157:105–32. [PubMed: 7108955]
34. Bearden JA. X-Ray Wavelengths. Reviews of Modern Physics. 1967; 39:78. &.
35. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome
research. 2004; 14:1188–90. [PubMed: 15173120]
36. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol
Biol. 1990; 215:403–410. [PubMed: 2231712]
Shneider et al. Page 9
Nature. Author manuscript; available in PMC 2014 February 15.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 1.
Crystal structure of the VCA0105 PAAR-repeat protein bound to its VgrG-like partner. a,
Schematic representation of the conserved domains comprising the VgrG-PAAR complex.
The last strands of the β -helix that form the PAAR binding site are in light blue. Gray arrow
shows the fragment roughly corresponding to the crystal structure. b, Molecular surface
representation of the gp5_VCA0018-VCA0105 complex crystal structure. Each protein
chain is labeled with its own color. c, Ribbon diagram of the gp5_VCA0018- VCA0105
complex. d, The polypeptide chain of the VCA0105 PAAR protein is colored in rainbow
colors with N terminus in blue and C terminus in red. Residues responsible for Zn binding
are labeled.
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PAAR proteins are required for full functionality of the T6SS in Vibrio cholerae and
Acinetobacter baylyi. a, Recovery of viable E. coli MG1655 after co-incubation with A.
baylyi ADP1 (WT) and its T6SS and PAAR genes knockout mutants. The following genes
were inactivated in the mutants shown: T6S¯ – aciad2688 to aciad2694; 2681¯ – aciad2681;
0051-52¯ – both aciad0051 and aciad0052; 3×P¯ – all three PAAR genes aciad0051,
aciad0052 and aciad2681. Right subpanel: Leaky, basal expression of the aciad2681 PAAR
gene from plasmid pMMB67EH26, labeled as p2681, restores the killing defect in the triple
PAAR mutant. b, Recovery of E. coli MG1655 colony forming units after co-incubation
with V. cholerae 2740-80 and its T6SS and PAAR genes knockout mutants, which are
labeled as follows: T6S¯ – vipA; 105¯ – vca0105; 284¯ – vca0284; 2×P¯ – vca0105 and
vca0284. Symbols *, **, and *** indicate deviations from the WT with p-values of 6×10−3,
8×10−3, and 5×10−7, respectively, for a sample size of 8. Error bars represent one standard
deviation. c, SDS-PAGE assay for T6SS-dependent secretion of Hcp proteins by the
parental strains and T6SS and PAAR genes knockout mutants. Panels a and c show one out
of three experiments with similar outcomes.
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The vsvG epitope-tagged PAAR protein ACIAD2681 is secreted by A. baylyi ADP1. Left
panels: T6SS-dependent secretion of vsvG epitope-tagged ACIAD2681 expressed from
plasmid pMMB67EH. Right panel: vsvG epitope-tagged ACIAD2681 fully restores the Hcp
secretion defect of the triple knockout PAAR mutant of A. baylyi ADP1. The mutants are
labeled as in Fig. 2. A representative of three identical experiments was chosen for each
panel.
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Multiple Effector TRanslocation VgrG (MERV) model for the organization of the T6SS
central spike/baseplate. Effectors are predicted to be loaded onto the spike complex by five
distinct mechanisms: 1) C-terminal extensions of the VgrG spike; 2) Non-covalent binding
to the VgrG spike; 3) N- or C-terminal extensions of the PAAR protein; 4) Non- covalent
binding to the PAAR protein or its extension domains; 5) Incorporation into the cavity
formed by the gp27 domain of VgrG. A single T6SS sheath contraction event translocates
the VgrG spike with all of its cargo proteins into a nearby target cell. Other proteins making
up the T6SS “baseplate” are not labeled but presumably reside within or attached to the
inner and outer membranes and peptidoglycan layer (IM, OM, and PG, respectively).
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